Carpenter (CRS) Q3 2026 Earnings Call Transcript

Carpenter Technology reported record third-quarter operating income of $186.5 million, up 20% sequentially, with adjusted free cash flow of $124.8 million and SAO operating margin expanding to a record 35.6%. Management raised full-year 2026 adjusted free cash flow guidance to at least $350 million and said operating income outlook implies at least 33% growth over fiscal 2025. Demand remains strong across aerospace, defense, and IGT energy, while the company continues aggressive buybacks and highlighted a strong liquidity position of $793.8 million.

Analysis

CRS is entering the part of the cycle where operating leverage compounds: mix, pricing, and utilization are all moving in the same direction while incremental demand is still under-ordered. The key second-order effect is that the company is not just taking share from a better market; it is monetizing supply-chain stress, which usually shows up later in lead times, emergency orders, and stronger contract terms. That means earnings power for the next 2-4 quarters is likely more a function of customer behavior than of end-market GDP.

The more important medium-term setup is capacity scarcity. If aerospace OEMs keep stepping rates and suppliers remain behind on inventory, CRS’s high-qualification alloy bottleneck becomes a pricing asset, not just a volume story. The brownfield project is therefore less about meeting current demand than about preserving pricing power by avoiding a future service-level miss; any slippage would be immediately visible through expedite intensity and lost structural share.

The market may still be underestimating the durability of capital returns here. Management is effectively signaling that incremental cash generation is now large enough to fund both growth capex and buybacks without levering up, which should support multiple expansion if the guide keeps getting revised higher. The main contrarian risk is that investor enthusiasm is front-running 2027/28 upside before the supply-chain squeeze translates into visible end-demand persistence; if Boeing/A&D pacing stalls or medical recovery remains delayed, the stock can de-rate quickly despite strong current-quarter optics.

Key Decisions for Investors

• Long CRS on any 2-3 day post-earnings consolidation; target a 3-6 month hold with upside driven by guide revisions and margin expansion. Risk/reward remains favorable as long as the stock is not pricing in a flat 2027.
• Pair trade: long CRS / short BA for 1-2 quarters. CRS benefits immediately from every additional build-rate step-up, while BA still carries execution and capital-intensity risk; this isolates the supplier bottleneck thesis.
• Buy CRS call spreads 3-6 months out rather than outright stock if chasing momentum; the setup is strong, but the stock can be sensitive to any OEM cadence wobble. Use spreads to cap theta and preserve upside into the next guidance update.
• Monitor for a tactical short in CRS only if expedite requests spike without corresponding inventory rebuild or if management signals structural orders are decelerating. That would indicate the demand pull-forward is being mistook for durable growth.
• Relative-value long CRS vs industrials or broad aerospace suppliers with weaker pricing power. CRS has the cleanest exposure to qualification scarcity and should outperform if defense/aerospace capex remains elevated.